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More than a million people die every year due to gastric cancer and peptic ulcer.
Helicobacter pylori infection in stomach is the most important reason for these diseases.
Interestingly, only 10–20% of the H. pylori infected individuals suffer from these gastric
diseases and rest of the infected individuals remain asymptomatic. The genotypes of
H. pylori, host genetic background, lifestyle including smoking and diet may determine
clinical outcomes. People from different geographical regions have different food habits,
which also include several unique fermented products of plant and animal origins. When
consumed raw, the fermented foods bring in fresh inocula of microbes to gastrointestinal
tract and several strains of these microbes, like Lactobacillus and Saccharomyces are
known probiotics. In vitro and in vivo experiments as well as clinical trials suggest
that several probiotics have anti-H. pylori effects. Here we discuss the possibility of
using natural probiotics present in traditional fermented food and beverages to obtain
protection against H. pylori induced gastric diseases.
Keywords: fermented food, probiotics, prevention of H. pylori infection, peptic ulcer, gastric cancer
INTRODUCTION
“Let food be thy medicine and medicine be thy food.”
Hippocrates (460 – 370 BC)
Every year peptic ulcer and gastric cancer takes approximately 301,000 and 740,000 lives,
respectively (Piazuelo and Correa, 2013; Naghavi et al., 2015). Although both diseases have multiple
etiologies like stress, diet, smoking and host genetic background, Helicobacter pylori infection
is perhaps the most critical among them (Malfertheiner et al., 2014). However, every H. pylori
infected individual does not develop peptic ulcer or gastric cancer. More than half of the world
population is infected by H. pylori, but 10–20% of the infected people suffer from these diseases
(Dorer et al., 2009). Why ∼80% of the H. pylori infected people in any given population never
suffer from gastric disorders is unknown at present. Also, the clinical outcomes among the H. pylori
infected population suffering from gastric disorders vary tremendously with geography (Covacci
et al., 1999). For example, gastric cancer is fairly common in East-Asian countries like Japan and
Korea, but in most African countries and India, the incidence of gastric cancer is low in spite of
having high prevalence of H. pylori infection (Holcombe, 1992; Singh and Ghoshal, 2006; Shiota
et al., 2013). Variations in bacterial and human genetic factors have been linked to explain the
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differences in clinical outcome, but our understanding of
H. pylori infection and related diseases are really incomplete.
Microbiota is the ecological community of commensal,
symbiotic and pathogenic microorganisms that literally share
our body space. Microbiome is the combined genomes of the
microbiota (Lederberg, 2001). Recent metagenomic analyses of
DNA isolated from gastric tissue specimens show that human
stomach is the niche of many bacterial species (Maldonado-
Contreras et al., 2011). While the exact significance of the
microbes that co-exist in highly acidic gastric milieu is not
understood till date, it seems apparent that H. pylori infection can
alter the dynamics of gastric microbiota (Andersson et al., 2008).
However, microbiota can also be modulated by several other
factors like alteration in immunity due to other infections and
change in lifestyle including food and beverage consumptions
(De Filippo et al., 2010). Interestingly, almost every geographical
location has unique tradition of consuming fermented foods and
beverages (Campbell-Platt, 1987). These fermented foods are rich
source of bacteria, yeasts and molds and many of these microbes
provide benefits to hosts and act as probiotics (Tamang et al.,
2016a,b). More intriguingly, adding purified probiotics to therapy
against H. pylori gives better eradication rate and reduces the
side effects of antibiotics (Zhang et al., 2015). Unfortunately,
however, the significances of the natural probiotics in traditional
fermented foods and beverages are less studied in the context
of H. pylori associated diseases. In this mini-review, we will
discuss how probiotics present in different fermented foods and
beverages may have a role in preventing H. pylori related gastric
diseases.
H. pylori INFECTION AND GASTRIC
DISEASES
Presence of spiral bacilli in stomach have been reported several
times during the past century, but the culture of this slow growing
species remained unsuccessful until a serendipitous prolonged
incubation of human gastric specimens in microaerophillic
conditions during Easter holidays by Barry James Marshall and
John Robin Warren (Doenges, 1938; Freedberg and Barron,
1940; Warren and Marshall, 1983; Marshall and Warren, 1984).
To prove Koch’s postulate Barry Marshall drank pure culture
of H. pylori, which resulted in hypochlorhydric vomiting and
gastritis before he was treated with antibiotics (Marshall et al.,
1985). Subsequently, a huge number of studies confirmed the role
of H. pylori virulence factors in peptic ulcer and gastric cancer
and H. pylori was classified as a type I carcinogen by WHO
(Malfertheiner et al., 2014).
H. pylori expresses many virulence factors, but two
multitasking proteins, the vacuolating cytotoxin (VacA)
and the cytotoxin-associated gene A (CagA), seem to play the
most crucial role in developing the gastro-duodenal diseases. The
VacA is a secreted toxin, which forms large cytoplasmic vacuoles
inside the host cells (Leunk et al., 1988). The VacA is also
involved in reducing mitochondrial transmembrane potential,
releasing cytochrome c, inducing cell death, activating MAP-
kinases and inhibiting T-cell activation (Galmiche et al., 2000;
Gebert et al., 2003; Willhite and Blanke, 2004; Yamasaki et al.,
2006; Torres et al., 2007). The vacA gene has mosaic structures
viz. s1/s2 alleles (encoding signal peptides), m1/m2 alleles
(encoding mid-regions) and i1/i2/i3 (encoding intermediate
regions) (Cover et al., 1994; Atherton et al., 1995, 1999; Rhead
et al., 2007). The s1 and the i1 alleles of vacA are associated with
aggressive clinical outcomes (Rhead et al., 2007; Yamaoka, 2010).
The H. pylori strains carrying vacA s1 usually carry cagA gene,
which is located in the cag-pathogenicity island (Blaser et al.,
1995; Xiang et al., 1995; Yamaoka, 2010). The cagA+ strains are
associated with more severe diseases in most regions (Blaser
et al., 1995). The cagA gene shows length polymorphism at
the 3′ end and this variable region encodes EPIYA motifs that
undergo phosphorylation once the CagA protein is translocated
into the host cells (Yamaoka et al., 1998; Higashi et al., 2002).
The phospho-CagA interacts and deregulates the SHP-2 protein,
which leads to cancer, but the CagA can hijack cellular pathways
also by phosphorylation independent manner (Higashi et al.,
2002; Hatakeyama, 2014).
Polymorphisms in host immune genes also contribute
to determine the clinical status of the host (Datta De
and Roychoudhury, 2015). For example, polymorphisms in
interleukin-1 (IL1) and tumour necrosis factor (TNF) genes
have been shown to play important roles in progression of
gastric diseases among Scottish, Japanese, American, and Indian
populations (El-Omar, 2001; Datta De and Roychoudhury, 2015).
Moreover, every geographic region has unique lifestyle including
food and beverage intakes, which are known to have effects on
gut microbiota (De Filippo et al., 2010).
It is now appreciated that human stomach microbiota consists
of 44 bacterial phyla, dominated by four phyla: Proteobacteria,
Firmicutes, Actinobacteria, and Bacteroidetes (Maldonado-
Contreras et al., 2011). A study using Swedish patients showed
that the presence of H. pylori in stomach may significantly
alter the relative abundance of other bacteria (Andersson et al.,
2008). Colonization by specific groups of bacteria seems to
correlate with H. pylori infection status. H. pylori colonization
dramatically reduced the diversity and increased the colonization
of Proteobacteria. Positive H. pylori status in America is
also associated with increased abundance of Proteobacteria,
Spirochetes and Acidobacteria, and with decreased abundance
of Actinobacteria, Bacteroidetes and Firmicutes (Maldonado-
Contreras et al., 2011). Recently, in mouse, it has been shown that
H. pylori colonization can influence both gastric and intestinal
microbiota (Kienesberger et al., 2016). While it appears that the
stomach and intestinal microbiota in the presence and in the
absence of H. pylori infection may have a role in gastric diseases
the mechanism is not known.
Treatment for all H. pylori infections has been recommended
for several geographical locations (Shiota et al., 2013; Malnick
et al., 2014). The usual treatment regimen for H. pylori is
a short course of two antibiotics (mostly clarithromycin and
amoxicillin) along with proton pump inhibitors (e.g., omeprazole
or lansoprazole). The treatment, however, is complicated by
several factors like bacterial resistance to antibiotics, re-infection,
side effects (bloating, diarrhea and taste disturbances) and
alteration of healthy gut microbiota (Malnick et al., 2014;
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Zhang et al., 2015). The destruction of the commensal flora
may lead to increased prevalence of opportunistic pathobionts,
like Clostridium difficile (Malnick et al., 2014). Hence, the
treatment of H. pylori using antibiotics has the risk for microbiota
imbalance or dysbiosis, which may lead to other diseases. Also,
eradication of H. pylori may lead to esophageal cancer (Blaser,
2008; Blaser and Falkow, 2009). Therefore, alternative approach
that can eradicate or prevent H. pylori infection without affecting
gut microbiota is needed.
USE OF PROBIOTICS FOR THE
ERADICATION OF H. pylori
Probiotics (means ‘for life’) are live microorganisms
which provide beneficial effects when taken in sufficient
quantity. Examples include several species of Lactobacillus,
Bifidobacterium, Enterococcus, Lactococcus, Streptococcus as
well as Saccharomyces (Reid, 1999; Fijan, 2014). Probiotics are
known to have beneficial roles in curing antibiotic associated
diarrhea, constipation, traveler’s diarrhea, food allergies and
cancer (McFarland, 2007; Chmielewska and Szajewska, 2010;
Hempel et al., 2012; Isolauri et al., 2012; Russo et al., 2014).
Lactobacillus is normally present in human intestinal tract
including stomach and it is tolerant to acid and bile (Ruiz
et al., 2013). Therefore, Lactobacillus is an attractive candidate
for probiotic for the treatment of H. pylori related gastric
diseases. Bhatia et al. (1989) showed that the culture supernatant
of Lactobacillus acidophilus inhibits H. pylori in vitro due
to an extracellular secretory product. Direct application of
L. acidophilus on blood agar plate can also inhibit H. pylori
(Vilaichone et al., 2002). Subsequently, it was found that both
L. acidophilus and L. casei subsp. rhamnosus can inhibit H. pylori
due to the production of lactic acid (Midolo et al., 1995; Enany
and Abdalla, 2015). The lactic acid produced by L. casei strain
Shirota inhibits 70% of urease activity in vitro and significantly
reduces the levels of H. pylori colonization in mouse model
(Sgouras et al., 2004). Lorca et al. (2001) studied antibacterial
activity of 17 Lactobacillus strains on 10 H. pylori strains and
concluded that the inhibition was due to acid production. They
also found that autolysis of L. acidophilus after 24 h of culture
releases a proteinaceous compound and this event is related to
the bactericidal effect (Lorca et al., 2001). Furthermore, H. pylori
colonized mice when treated with a commercial mixture of live
probiotics (L. rhamnosus, strain R0011, and L. acidophilus, strain
R0052) they suppressed colonization of H. pylori strain SS1
(Johnson-Henry et al., 2004).
The sulfatide-binding protein of the L. reuteri competes
and binds to the gangliotetraosylceramide (asialo-GM1) and
sulfatide, which are putative receptors of H. pylori (Mukai et al.,
2002). Weissella confusa can inhibit H. pylori adherence to human
gastric cell line by 90%. (Nam et al., 2002).
H. pylori infected MKN45 cells showed increased expression
of Smad7 and NFkB, and induced pro-inflammatory cytokines
IL-8 and TNF-α in vitro. Probiotic L. acidophilus pre-treatment,
however, inactivate the Smad7 and NFkB pathways and reduces
the H. pylori induced inflammation (Yang et al., 2012). Using
gnotobiotic murine model, it was shown that L. salivarius
infection also inhibits the colonization of H. pylori and associated
inflammatory responses like IL-8 release (Kabir et al., 1997; Avía
et al., 1998).
Since in vitro experiments and in vivo mouse studies showed
promising results, a significant number of clinical trials have
been performed in the recent past (Table 1). Several meta-
analyses published in 2013 revealed that addition of probiotics
in triple therapy against H. pylori improves overall efficacy and
reduces the side effects of therapy like nausea, diarrhea metallic
taste, abdominal/epigastric pain (Ruggiero, 2014). However, it
needs further improvement since the benefits conferred by
the probiotics are often not too remarkable. For example,
a meta-analysis based on literature search strategy suggest
that use of probiotics (mostly Lactobacillus, Bifidobacterium
and Streptococcus and in few trials Enterococcus, Clostridium,
Saccharomyces etc) in triple therapy improve eradication rate of
H. pylori by∼10% and reduce adverse effects of therapy by∼15%
(Zhang et al., 2015).
ROLE OF FERMENTED FOODS AND
BEVERAGES AGAINST H. pylori
ASSOCIATED DISEASES
Fermentation of food dates back to the early ages of human
evolution and provides an effective way of preserving food
for longer durations (McGovern et al., 2004). Many of the
bacteria, yeasts and molds that are present in fermented foods
and beverages are known probiotics and probably provide
health benefits when consumed raw (Stanton et al., 2005).
The significance of the microbes present in fermented food in
maintaining human health was first noticed by Elie Metchnikoff
(Mackowiak, 2013). He hypothesized that the long and healthy
lives of Bulgarian peasants were due to the regular consumption
of sour milk and yogurt containing the necessary beneficial
microbes (Mackowiak, 2013).
Many of the probiotic that are isolated directly from the
fermented foods, particularly fermented dairy products, have anti
H. pylori effects. Based on dietary interviews it was found that
yogurt, but not unfermented dairy products, when consumed
one serving per week or more has protective effect against
H. pylori infection in Mexican population (Ornelas et al., 2007).
Several strains of Lactobacilli and two strains of yeast directly
isolated from yogurt were found to have inhibitory effect on
H. pylori (Oh et al., 2002). A meta-analysis of randomized
controlled trials shows that there is ∼10% improvement in
eradication rates when using fermented milk based probiotics,
which seems to be better than capsule/sachet-based bacteria-
only preparations (Sachdeva and Nagpal, 2009). Similarly, 4-week
treatment with L. gasseri-containing yogurt improved the efficacy
of triple therapy in patients with H. pylori infection (Deguchi
et al., 2012). Another study showed that H. pylori infected
children have a lower number of Bifidobacterium in their gut,
but intake of probiotics-containing yogurt had multiple effects
like, restoration of Bifidobacterium, reduction of H. pylori load,
increase in IgA and decrease in IL-6 (Yang and Sheu, 2012). Three
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TABLE 1 | Some of the anti-Helicobacter pylori clinical trials and meta-analyses that used probiotics.
Study Species Results Reference
Meta-analysis Lactobacillus strains Improvement in eradication rates Zheng et al., 2013
Randomized open label clinical study Bifidus infantis Used as adjuvant improves cure rate Dajani et al., 2013
Meta-analysis Lactobacillus and Bifidobacterium species Beneficial effects on eradication rate and
incidence of side effect
Wang et al., 2013
Meta-analysis Lactobacillus acidophilus, Lactobacillus
casei DN-114001, Lactobacillus gasseri,
Bifidobacterium infantis 2036.
Increases eradication rates Dang et al., 2014
Clinical trials Lactobacillus gasseri OLL2716(LG21) Supression of H. pylori, reduction in gastric
mucosal inflammation
Sakamoto et al., 2001
Double blind randomized
placebo-controlled crossover clinical study
Lactobacillus reuteri strain SD2112 Suppression of urease activity and H. pylori
density
Imase et al., 2007
Double blind placebo-controlled study Lactobacillus reuteri ATCC 55730 Suppresses H. pylori infection, decreases
the occurrence of dyspeptic symptoms
Francavilla et al., 2008
Double blind placebo-controlled study Lactobacillus reuteri ATCC 55730 H. pylori eradicated in half of the patients by
omeprazole plus L. reuteri
Saggioro et al., 2005
Double blind randomized
placebo-controlled study
Lactobacillus reuteri DSM 17938,
Lactobacillus reuteri ATCC PTA 6475
Combination of both strains alone exert an
inhibitory effect and when used with
eradication therapy reduces side effects
Francavilla et al., 2014
Open label single center study Lactobacillus reuteri DSM 17938 Reduction of urease activity Dore et al., 2014
Single center, double-blind, prospective,
randomized, placebo-controlled trial
Lactobacillus GG Reduced side effects and overall treatment
tolerability
Armuzzi et al., 2001
strains of lactic acid bacteria, LY1, LY5 AND IF22, which are
from the spent culture supernatant of fermented milk, showed
anti-H. pylori effect (Lin et al., 2011). In china, several probiotics
from traditional fermented foods were isolated and two strains
of Lactobacillus- L. plantarum 18 and L. gasseri showed potential
anti-H. pylori activity (Chen et al., 2010). Kefir, a fermented milk
product was found to be effective in eradication and reducing side
effects when used along with triple therapy (Bekar et al., 2011). An
in vitro study proved that L. plantarum (MLBPL1) isolated from
sauerkraut (fermented cabbage) had an anti-Helicobacter activity
(Rokka et al., 2006). Interestingly, the main inhibitory activity is
mostly associated with cell wall.
Unfortunately, however, anti-H. pylori activity alone does
not ensure protection from gastric diseases and gastric cancer
may sometimes develop even after eradication of H. pylori
since some of the H. pylori proteins like CagA may act by ‘hit
and run’ mechanism (Shiota et al., 2013; Hatakeyama, 2014).
More interestingly, prevalence of H. pylori and incidence of
gastric diseases does not match in some countries. In Africa
and India, the prevalence of H. pylori infection and associated
gastritis is high, but the incidence of gastric cancer is very low
(Holcombe, 1992; Singh and Ghoshal, 2006). On the other hand,
East-Asian countries like Japan and Korea have high rates of
gastric cancer (Singh and Ghoshal, 2006). Genotype alone cannot
be responsible to explain the clinical outcome since nearly all
H. pylori strains isolated from East-Asia are virulent (Shiota
et al., 2013). Therefore, it is intriguing to compare the microbes
that are present in traditional fermented foods and beverages
of Japan or Korea and African countries (Table 2). Apparently,
fermented foods in African countries are based on milk, beans,
grains and roots. They are dominated by Lactobacillus and other
lactic acid bacteria. Conversely, Japanese fermented foods are
primarily based on rice, soy and fish and these foods have varieties
of bacteria and fungi. Interestingly, the soy foods may reduce the
risk for gastric cancer, while high salt containing foods might be
a risk factor in Japan and Korea (Hirayama, 1981; Woo et al.,
2013).
A similar comparison would be exiting between the fermented
foods of ethnic populations in North-Eastern India (e.g., ethnic
populations in Sikkim state like Bhutias) and Mid-Eastern India
(e.g., ethnic population of Jharkhand and West Bengal states like
Santhals). North-Eastern states have highest incidence of gastric
cancer in India (Pradhan et al., 2003–2004). This high prevalence
has been thought to be due to smoking and high salt consumption
that possibly come from fermented and pickled foods including
fish and meat (Phukan et al., 2005; Verma et al., 2012). Recent
analyses of some of the fermented foods showed presence of
huge microbial variety but their significances in gastric diseases
have not been studied (Tamang and Sarkar, 1996; Tamang et al.,
2016a,b). Unfortunately, not much is known about the microbes
that are present in fermented foods consumed by the Santhals.
But interestingly, they regularly consume intoxicating alcoholic
beverages like Handia and Mahua fermented in traditional way
and these beverages are not common elsewhere (Kumar and Rao,
2007). Among Santhals, infections with virulent H. pylori strains
are extremely common without any manifestation of gastric
diseases (Datta et al., 2003).
Our current understandings of microbes present in the
ethnic fermented foods are incomplete at present, but with
modern methodologies like metagenomic analysis using Next-
generation sequencing the microbial species are now easy to
identify (Mozzi et al., 2013). However, to prove or disprove
the hypothesis—whether or not microbes present in the ethnic
fermented food can protect certain population from peptic ulcer
or gastric cancer is very tricky, particularly when H. pylori
infection is not the only determinant in precipitating the
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TABLE 2 | Microbes present in traditional fermented foods and beverages in Japan and Africa.
Fermented
food
Ingredients Microorganism Known probiotics or
anti-H. pylori
activity
Country Reference
Fermented food of Japan and Korea
Sake Rice Aspergillus sojae, Bacillus subtilis
and lactic acid bacteria
Lactic acid bacteria and
Bacillus subtilis
Japan Sakaguchi, 1958a,b
Narezushi Fish, salt and cooked rice L. plantarum and L. brevis L. plantarum Japan Kiyohara et al., 2012
Takju Rice Lb. harbinensis, Lb. parabuchneri
Lactobacillus (Lb.) paracasei, Lb.
plantarum, and Leuconostoc
pseudomesenteroides
L. plantarum Korea Kim et al., 2010
Vinegar Rice Aspergillus oryzae, Lactobacillus
acetotolerance, Acetobacter
pasteurianus, Saccharomyces sp.
and lactic acid bacteria
Lactic acid bacteria and
Saccharomyces sp.
Japan Haruta et al., 2006
Natto Soybean Bacillus subtilis Bacillus subtilis Japan Kubo et al., 2011
Starch
Noodle
Starch from sweet potato,
mung bean etc
L. casei, L. cellobiosus, L. fermenti L. casei Korea,
Japan
Rhee et al., 2011
Kimchi Korean cabbage, radish,
various vegetables, salt
L. mesenteroides, L. brevis, L.
plantarum
L. plantarum Korea Rhee et al., 2011
Miso Soybean and sometime
rice or barley
Aspergillus oryzae Saccharomyces
cerevisiae and lactic acid bacteria
Lactic acid bacteria and
Saccharomyces sp.
Japan Hirayama, 1981
Komesu
and kurosu
Rice Aspergillus oryzae, Saccharomyces
cerevisiae and acetic acid bacteria
Saccharomyces sp. Japan Nanda et al., 2001
Tempeh Soybean Rhizopus sp. ? Japan Aoki et al., 2003
Fermented food of Africa
Rigouta Milk Lactococcus lactis and
Enterococcus faecalis
Enterococcus faecalis Tunisia Ghrairi et al., 2004
Wara Cow milk Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Ugba Oil bean seed Bacillus subtilis Bacillus subtilis Nigeria Olasupo et al., 1997
Fufu Cassava Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Ogi Maize Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Kunu-zarki Millet Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Kenkey Maize Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Iru African locust bean Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria Olasupo et al., 1997
Garri Cassava Yeast, Lactobacillus plantarum,
Leuconostoc fallax, Lactobacillus
fermentum and other lactic acid
bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Nigeria and
other part
of Africa
Kostinek et al., 2005
Kule naoto Milk Lactobacillus plantarum and other
lactic acid bacteria
Lactobacillus plantarum and
other lactic acid bacteria
Maasai in
Kenya
Mathara et al., 2004
Poto Poto Maize dough Lactobacillus plantarum, Bacillus
sp., Lactobacillus reuteri,
Lactobacillus casei and other lactic
acid bacteria
Lactobacillus plantarum,
Lactobacillus reuteri,
Lactobacillus casei
Congo Abriouel et al., 2006
Degue Pearl millet dough Lactobacillus plantarum, Bacillus
sp., Lactobacillus reuteri,
Lactobacillus casei, other lactic
acid bacteria and yeast and molds
Lactobacillus plantarum,
Lactobacillus reuteri,
Lactobacillus casei
Burkina
Faso
Abriouel et al., 2006
gastric diseases (Parekh et al., 2014; De and Roychoudhury,
2015). How the microbes present in the ethnic fermented food
can alter the pathogenicity of H. pylori in combination with
gastric and duodenal microbiome as well as host immunity
for different population is perhaps the key question at
present.
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CONCLUSION
H. pylori infection is the major risk factor for peptic ulcer
and gastric cancer and the eradication of this bacterium
using antibiotics is often unsuccessful. Several microbes with
known probiotic activities are shown to have inhibitory effects
against H. pylori in vitro and in vivo. Inclusion of probiotics
in triple therapy leads to improved efficacy and reduced
side effects. Most traditional fermented foods and beverages
are natural sources of probiotic microbes. Microbes directly
isolated from the fermented products are shown to have anti-
H. pylori activity. Few studies showed that consumption of
probiotics containing yogurt and kefir are somewhat beneficial
in the context of H. pylori infection. Many ethnic populations
have significantly low incidences of peptic ulcer and gastric
cancer in spite of having very high prevalence of H. pylori
infection. Incidentally, each ethnic population also has unique
tradition of consuming fermented food and beverages that
contain probiotics. It is intriguing to hypothesize that regular
consumptions of these probiotics may have protective effect
against peptic ulcer and gastric cancer for some populations.
Analyzing these traditional fermented foods and beverages using
modern techniques is needed to understand these microbes and
their significances.
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